The cost, which is confidential and was negotiated for a total of 300 huge number of doses, is a little less than the $19.50 per photo the United States agreed to pay for a first shipment of hundred million doses of the same vaccine, in series with what Reuters reported in November.
The EU file dated Nov. eighteen was circulated internally right after the EU announced its supply offer with Pfizer and the German partner BioNTech of its on Nov. eleven.
The EU drug regulator is likely to decide on Monday on approval for the Pfizer vaccine following the shot was authorised in a few countries, including Britain and the United States.
On Thursday Belgian say secretary for the budget Eva De Bleeker printed on Twitter a dining room table with price tags Belgium will pay pharmaceutical companies for the COVID-19 vaccines of theirs. She retracted the post shortly after publishing.
In that dinner table the Pfizer vaccine was suggested as costing Belgium 12 euros ($14.6) a dose, top many to believe this was the full price agreed by the EU.
Various other vaccines in the family table were additionally shown with prices lower compared to rates disclosed by EU solutions.
“There is , obviously , a full price along with a cost after delivery,” an EU official required in talks with vaccine creators told Reuters when made to clarify the big difference between the Belgian and EU prices.
A spokesman for De Bleeker declined to comment on Monday, citing confidentiality needs, but pointed to what De Bleeker told the Belgian parliament previous week. In that public hearing, De Beeker said Belgium’s budgeted price tags were still partial.
Under EU prior purchase deals for COVID 19 vaccines, the bloc concurs initial payments with business enterprises to secure doses before they are approved. After approvals, EU governments can pay the remainder to buy reserved doses.
The EU hasn’t revealed the upfront payment agreed with Pfizer.
But, it said in October which it paid aproximatelly one billion euros in downpayments to AstraZeneca, Sanofi and Johnson and Johnson for their shots, with a further 1.45 billion euros budgeted for upfront payments to Pfizer-BioNTech, Curevac and Moderna.
It’s since agreed supply deals with all six organizations and it is negotiating a seventh arrangement with Novavax.